The global market for the QuantiFERON-TB Gold (QFT) test—a leading Interferon-Gamma Release Assay (IGRA) used to diagnose Latent Tuberculosis Infection (LTBI)—is experiencing robust growth, driven primarily by the global shift away from the less specific Tuberculin Skin Test (TST). The QFT test, notably the latest version, QuantiFERON-TB Gold Plus (QFT-Plus), offers superior specifici... https://logcla.com/blogs/1000501/The-Impact-of-Miniaturization-and-Lightweight-Design-on-the-Adoption